Social Media Ideas for Bone Graft Substitute

Isto Biologics strengthens its bone graft substitutes platform with the acquisition of NovaBone

Bone Biologics Bets on a More Selective Path to Spine Fusion

For most of the past two decades, the orthobiologics shelf has been defined by a familiar tradeoff.

Isto Biologics Strengthens its Bone Graft Substitutes Platform with the Acquisition of NovaBone

Isto Biologics has acquired NovaBone Products from Halma plc, expanding its synthetic bone graft portfolio and global reach in orthopedic and dental markets.

Isto Biologics strengthens its bone graft substitutes platform with the acquisition of NovaBone

HOPKINTON, MA – August 5, 2026 – Isto Biologics (“Isto”), a biologics company dedicated to advancing bone healing,…

VB Spine Receives FDA Clearances of Expanded Indications for Vitoss® Bone Graft Substitute and Interbody Cage Portfolio

NEW YORK, July 29, 2026 -(BUSINESS WIRE)- VB Spine LLC (“VB Spine”) today announced that the U.S. Food and…

Coral-inspired scaffold reprograms immune cells to accelerate bone regeneration

A coral-inspired scaffold that combines multi-walled carbon nanotubes with nano-hydroxyapatite has shown promise in restoring bone regeneration in steroid-induced osteonecrosis of...

Bone Biologics Expands Trial Sites

Addition of three sites strengthens expectation to complete enrollment by year-end 2026 BURLINGTON, MA, Sept. 08, 2026 (GLOBE…

VB Spine Receives FDA Clearances of Expanded Indications for Vitoss® Bone Graft Substitute and Interbody Cage Portfolio

VB Spine LLC  announced that the FDA granted two 510(k) clearances that expand the indications for its Vitoss® Bone Graft Substitute and interbody cage portfolio.

CMS Finalizes Higher Payment for CERAMENT® G in the US

08-03-2026 – BONESUPPORT™, a leading company in orthobiologics for the management of bone injuries, today announces that the…

Vivex Biologics Launches VIA Linxâ„¢, a Novel Self-Assembling Synthetic Peptide Matrix, Expanding its Portfolio of Advan...

New molecular medical device joins Vivex's growing suite of allograft and advanced wound care technologies.

Suture bridge fixation demonstrates ‘excellent’ healing rate

SEATTLE — Absorbable single-stay suture bridge fixation may be a viable option for osteochondral fractures after patellar dislocation with low reoperation, good patient-reported ou...

Anabolic Bone Therapy Cuts Junctional Failure Risk 49%

Can spine surgeons cut the risk of proximal junctional kyphosis in half by attending to bone quality pre-operatively?

Bone Biologics Issues Mid-Year Shareholder Update Highlighting Progress Across 2026 Priorities

Strengthened capital position supports continued advancement of NB1 clinical development, manufacturing readiness and intellectual property initiatives through Q2…

Bioretec receives FDA 510(k) clearance for its ActivaScrewâ„¢ Cannulated COM bioabsorbable compression screw

September 8, 2026 – Bioretec Ltd (“Bioretec” or the “Company”), a pioneer in bioabsorbable orthopedic implants, has received…

INFUSE Bone Graft for TLIF receives eligibility for Medicare New Technology Add-on Payment, Advancing Reimbursement Supp...

GALWAY, Ireland, September 2, 2026 – Medtronic (NYSE: MDT), a global leader in healthcare technology announced that the…

Ortho Solutions Inc. is delighted to announceВ a Collaboration with CybionВ® GmbH,В enabling the usage of the original T...

September 4, 2026 / OrthoSpineNews / – The original CybionВ®-В BFIXВ® TTT System has been developed to support surgeons treating…

Nanochon Performs First Case in the Chondrograftâ„¢ First in Human Clinical Study

Nanochon announced the successful treatment of the first patient in its First-in-Human (FIH) clinical study of its Chondrograft cartilage implant.

GMReis Receives FDA 510(k) Clearance for the VersaLock® Sterile Plating System, Advancing Its Single-Use Trauma Strategy...

GMReis has received FDA 510(k) clearance K262537 for the VersaLock® Sterile Plating System, completing 510(k)-cleared sterile implant solutions across its upper and lower extremity...

Nanochon Performs First Case in the Chondrograftâ„¢ First in Human Clinical Study

BALTIMORE, Sept. 2, 2026 /PRNewswire/ — Nanochon, a medical device company developing Chondrograft™, a novel 3D-printed patented implant for the…

Bone's Hidden Battery: Future of Fracture Healing?

A fracture appears almost lifeless on postoperative radiographs. Weeks later, almost imperceptibly, biology awakens.

Sulfated polysaccharides target RANK Lys97 to inhibit osteoclast differentiation and reverse osteoporosis

Current osteoporosis treatments fail to balance bone resorption and formation. Here we show that engineered 2-N,6-O-sulfated chitosan (26SCS), a synthetic pentasaccharide, restores...

AlloPort Launches on September 1 Leveling the Playing Field for Accredited Tissue Banks and Expanding Hospital Access to...

AlloPort today announced its planned public launch on September 1, 2026, followed by its industry debut at the AATB Annual Conference in San Francisco on October 4.

FibroBiologics Announces Chondrocyte Spheroids Demonstrate Cartilage Repair in Preclinical Study of Degenerative Joints

Animal trials show cartilage repair within four weeks following a single injection of chondrocyte spheroids

CMS Finalizes Higher Payment for CERAMENT® G in the US

CMS has confirmed the DRG reassignment for CERAMENT® G in the final Medicare IPPS rule for fiscal year 2027, assigning qualifying cases to the highest reimbursing DRGs within their...